Jefferies Raises CELG Price Target to $ 104. (( LINK ))
Celgene price target raised to $104 from $94 at Jefferies
Jefferies raised its estimates and price target for Celgene citing the company's new 2017 guidance, which the firm says reflects stronger than expected operating margin leverage. Jefferies keeps a Buy rating on Celgene, which was upgraded this morning at both RBC Capital and Piper Jaffray.